Not checked for notices yet.
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine.
Seth M Pollack, Yonqing Li, Megan J Blaisdell and 9 more
PLoS ONE · 2012
doi:10.1371/journal.pone.0032165
Cited by papers we hold 1
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives · 2018No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.